Déférasirox - EXJADE 125 mg, comprimé dispersible

Business Listing - December 25, 2019

Déférasirox EXJADE 125 mg, comprimé dispersible - V03AC03 NOVARTIS EUROPHARM (ROYAUME-UNI) - 67037109

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.